Fear of Recurrence and Stopping Immunotherapy

Launched by UNIVERSITY OF PITTSBURGH · Feb 16, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on helping people who have finished their immunotherapy treatment for cancer but are feeling anxious or fearful about their cancer coming back. The study will use a type of therapy called cognitive-behavioral therapy (CBT) to help participants manage their worries, as well as feelings of depression and anxiety. The goal is to improve their overall quality of life during this challenging time.

To participate, individuals must be at least 21 years old, speak English fluently, and have a history of cancer treatment with immunotherapy. However, those who are currently experiencing severe mental health issues, such as thoughts of suicide or hallucinations, will not be eligible. Participants will have the chance to engage in supportive therapy sessions aimed at reducing their distress and helping them feel more at ease after treatment. This trial is currently looking for new participants, so if you or someone you know fits the criteria, it could be a valuable opportunity.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 21 years and older
• • Fluent in English
• • Diagnosis of cancer and history of treatment with immunotherapy
• Exclusion Criteria:
• • Active suicidal ideation, delusions or hallucinations